Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2014-03-19

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1517/17425247.2014.881798PMID 24472170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria.

  2012cited by this paper
• Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.

  2012cited by this paper
• Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.

  2012cited by this paper
• Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.

  2011cited by this paper
• Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect.

  2011influential reference
• Enhancing and Sustaining AMG 009 Dissolution from a Matrix Tablet Via Microenvironmental pH Modulation and Supersaturation

  2011cited by this paper
• Enhancing and Sustaining AMG 009 Dissolution from a Bilayer Oral Solid Dosage Form via Microenvironmental pH Modulation and Supersaturation

  2011cited by this paper
• Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium.

  2010cited by this paper
• pH modulation: a mechanism to obtain pH-independent drug release

  2010influential reference
• Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility

  2010influential reference
• Review: physical chemistry of solid dispersions.

  2009cited by this paper
• Solid dispersions: a review.

  2009cited by this paper
• Citric acid as a pH-modifying additive in an extended release pellet formulation containing a weakly basic drug

  2009influential reference
• Review: physical chemistry of solid dispersions

  2009cited by this paper
• Systematic review: Heliocobacter pylori infection and impaired drug absorption

  2009cited by this paper
• Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

  2009cited by this paper
• Mechanisms of drug release in citrate buffered HPMC matrices.

  2009cited by this paper
• Strategies to Overcome pH-Dependent Solubility of Weakly Basic Drugs by Using Different Types of Alginates

  2008cited by this paper
• Measurement of surface pH of pharmaceutical solids: a critical evaluation of indicator dye-sorption method and its comparison with slurry pH method.

  2008cited by this paper
• Assessment of Tailor-Made HPMC-Based Matrix Minitablets Comprising a Weakly Basic Drug Compound

  2008cited by this paper
• Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.

  2008cited by this paper
• Solubility of sparingly-soluble ionizable drugs.

  2007cited by this paper
• Development of a Multiple Unit Pellet Formulation for a Weakly Basic Drug

  2007cited by this paper
• pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.

  2007cited by this paper
• Microenvironmental pH modulation in solid dosage forms.

  2007influential reference
• Drug disease interactions: role of inflammatory mediators in pain and variability in analgesic drug response.

  2007cited by this paper
• Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.

  2006influential reference
• Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389

  2006cited by this paper
• Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.

  2006cited by this paper
• A Review on Telmisartan: A Novel, Long-Acting Angiotensin II-Receptor Antagonist

  2006cited by this paper
• Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH.

  2006influential reference
• A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.

  2006cited by this paper
• Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.

  2005cited by this paper
• Spray Drying for Generation of a Ternary Amorphous System of Celecoxib, PVP, and Meglumine

  2005cited by this paper
• Accuracy of calculated pH-dependent aqueous drug solubility.

  2004cited by this paper
• pH-Related Changes in the Absorption of Dipyridamole in the Elderly

  2004cited by this paper
• The Effect of Citric Acid Added to Hydroxypropyl Methylcellulose (HPMC) Matrix Tablets on the Release Profile of Vinpocetine

  2004cited by this paper
• Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres

  2004cited by this paper
• Measurement and Mapping of pH in Hydrating Pharmaceutical Pellets Using Confocal Laser Scanning Microscopy

  2002cited by this paper
• Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

  2002cited by this paper
• Sustained-Release Preparations of Quinolone Antibiotics and Method for Preparation Thereof

  2001cited by this paper
• Assessment of gastric acidity of Japanese subjects over the last 15 years.

  2001cited by this paper
• Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets.

  2000cited by this paper
• pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets.

  2000influential reference
• Effect of different acids on solid-state stability of an ester prodrug of a IIb/IIIa glycoprotein receptor antagonist.

  1999cited by this paper
• Simultaneous quantification of released succinic acid and a weakly basic drug compound in dissolution media.

  1998cited by this paper
• Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.

  1997cited by this paper
• Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.

  1997cited by this paper
• Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 2. Cocompression of drugs with buffers.

  1997cited by this paper
• Effects of Spontaneous Gastric Hypoacidity on the Pharmacokinetics of Zidovudine and Didanosine

  1997cited by this paper
• Retardation of weakly basic drugs with diffusion tablets

  1990cited by this paper
• Low gastric hydrochloric acid secretion and mineral bioavailability.

  1989cited by this paper
• Microenvironmental pH control of drug dissolution

  1989cited by this paper
• Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans.

  1986cited by this paper
• Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: Salicylic acid, theophylline, and benzoic acid.

  1985cited by this paper
• Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine.

  1985cited by this paper
• Potential Development and New Approaches in Oral Controlled-Release Drug Delivery Systems

  1983cited by this paper
• Factors influencing gastric emptying.

  1979cited by this paper

• Activation-modulated stimuli-responsive systems: an intelligent platform for site-specific gastroretentive delivery of diverse therapeutic agents.

  2026cites this paper
• Advanced oral drug delivery systems: Current challenges and emerging technologies

  2025cites this paper
• EXPLORING MODERN TECHNIQUES FOR SOLUBILITY ENHANCEMENT IN DRUG FORMULATIONS

  2025cites this paper
• Physics-Based Solubility Prediction for Organic Molecules

  2025cites this paper
• Ternary Solid Dispersions as an Alternative Approach to Enhance Pharmacological Activity

  2025cites this paper
• Nasal powder formulation employing microenvironmental pH-modifier for rapid absorption of mirtazapine

  2025cites this paper
• Solid-State Modification Strategies for Alpha-Mangostin Solubility Enhancement: A Review on Recent Progress

  2025cites this paper
• Characterization and drug solubilization of arginine-based ionic liquids - Impact of counterions and stoichiometry.

  2024cites this paper
• Development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) for Ornidazole to improve solubility and oral bioavailability of BCS class II drugs

  2024cites this paper
• Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation.

  2024cites this paper
• New Drug Delivery Systems for Stable Oral Absorption: Theory, Strategies, and Applications.

  2024cites this paper
• Oral targeted drug delivery to post-gastrointestinal sites.

  2024cites this paper
• Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models

  2024cites this paper
• An overview of the methods used to increase the dissolution rate of meloxicam for oral administration

  2024cites this paper
• Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs

  2023cites this paper
• Review of commercially available nano-drugs and nano-delivery systems: challenges and perspectives

  2023cites this paper
• REVIEW PENGARUH PENGGUNAAN SURFAKTAN PADA KARAKTERISTIK SEDIAAN ORODISPERSIBLE FILM (ODF) OBAT BERKELARUTAN RENDAH DALAM AIR: SIFAT DISINTEGRASI DAN DISOLUSI

  2023cites this paper
• Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems

  2023cites this paper
• A Review On Stabilization Mechanism Of Amorphous Form Based Drug Delivery System

  2023cites this paper
• Oral Drug Delivery Systems Applied to Launched Products: Value for the Patients and Industrial Considerations.

  2023cites this paper
• Toltrazuril alkalizer-modifying solid dispersions againstToxoplasma gondii: a pharmacotechnical strategy to improve the efficacy of the drug.

  2023cites this paper
• Design, synthesis and application of tetraphenylethene substituted chalcones as pH and Et3N indicators

  2023cites this paper
• Microenvironmental pH Modification in Buccal/Sublingual Dosage Forms for Systemic Drug Delivery

  2023cites this paper
• Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline

  2022cites this paper
• Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution

  2022cites this paper
• ENHANCEMENT OF LORATADINE DISSOLUTION BY SURFACE SOLID DISPERSION: THE POTENTIAL USE OF CO-PROCESSED EXCIPIENTS AS ON-SURFACE CARRIERS

  2022cites this paper
• Pre-irradiation of surfactants to enhance their capacity to solubilisse drugs and dyes

  2022cites this paper
• Comparison study of physicochemical and biopharmaceutics properties of hydrophobic drugs ground by two dry milling processes

  2022cites this paper
• In Vitro and Ex Vivo Evaluation of Bi-Layered Effervescent Microenvironmental PH Modifying Buccal Films with Saquinavir

  2022cites this paper
• Development of an enhanced formulation to minimize pharmacokinetic variabilities of a weakly basic drug compound

  2022cites this paper
• Molecular mechanisms involved in supersaturation of Emodin ternary solid dispersions based on bonding agents.

  2022cites this paper
• pH-Dependent supersaturation from amorphous solid dispersions of weakly basic drugs

  2021cites this paper
• Hot-Melt Extruded Amorphous Solid Dispersion for Solubility, Stability, and Bioavailability Enhancement of Telmisartan

  2021cites this paper
• The evolution of commercial drug delivery technologies

  2021cites this paper
• Developing pH-Modulated Spray Dried Amorphous Solid Dispersion of Candesartan Cilexetil with Enhanced In Vitro and In Vivo Performance

  2021cites this paper
• Exploration of in vitro drug release testing methods for saquinavir microenvironmental pH modifying buccal films.

  2021cites this paper
• Enhancing therapeutic potential of poor aqueous soluble herbal drugs through solid dispersion-An overview

  2021cites this paper
• Supersaturated formulations of poorly soluble weak acid drugs evaluated in rodents; a case study.

  2021cites this paper
• FUNDAMENTAL ASPECTS OF A THIRD COMPONENT USED IN TERNARY SOLID DISPERSION: A REVIEW

  2021cites this paper
• Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.

  2021cites this paper
• Multi-material 3D printing of programmable and stretchable oromucosal patches for delivery of saquinavir.

  2021cites this paper
• Preparation and Characterization of Ibrutinib Amorphous Solid Dispersions: a Discussion of Interaction Force

  2021cites this paper
• Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation.

  2021cites this paper
• Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties

  2020cites this paper
• Stable solid dispersion of lurasidone hydrochloride with augmented physicochemical properties for the treatment of schizophrenia and bipolar disorder

  2020cites this paper
• The Case for Physiologically Based Biopharmaceutics Modelling (PBBM): What do Dissolution Scientists Need to Know?

  2020cites this paper
• Effect of excipients on oral absorption process according to the different gastrointestinal segments

  2020cites this paper
• Understanding powder behavior in pharmaceutical manufacturing to enhance drug productivity and therapeutic performance

  2020cites this paper
• Microenvironmental pH modifying films for buccal delivery of saquinavir: effects of organic acids on pH and drug release in vitro.

  2020cites this paper
• Design and optimization of a novel strategy for the local treatment of Helicobacter pylori infections.

  2020cites this paper
• Enhanced pharmacokinetic performance of dapoxetine hydrochloride via the formulation of instantly-dissolving buccal films with acidic pH modifier and hydrophilic cyclodextrin: Factorial analysis, in vitro and in vivo assessment

  2020cites this paper
• Mechanism and Improved Dissolution of Glycyrrhetinic Acid Solid Dispersion by Alkalizers

  2020cites this paper
• Nanonization techniques to overcome poor water-solubility with drugs

  2020cites this paper
• Using zeta potential to study the ionisation behaviour of polymers employed in modified-release dosage forms and estimating their pKa

  2019cites this paper
• A novel oil-based suspension of a micro-environmental, pH-modifying solid dispersion for parenteral delivery: Formulation and stability evaluation.

  2019cites this paper
• Formulation of aripiprazole‐loaded pH‐modulated solid dispersions via hot‐melt extrusion technology: In vitro and in vivo studies

  2019cites this paper
• Formulation and Evaluation of a Novel Oral Oil-Based Suspension Using Micro-environmental pH-Modifying Solid Dispersion

  2019cites this paper
• Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion

  2019cites this paper
• Amorphous solid dispersions of weak bases with pH-dependent soluble polymers to overcome limited bioavailability due to gastric pH variability - An in-vitro approach.

  2019cites this paper
• Relations structure-effet de nanovecteurs à base de copolymères à blocs pour la thérapie photodynamique : utilisation de modèles de membranes. (Structure-effect relationship of bloc copolymer based nanocarriers for photodynamic therapy : the use of model membrane)

  2019cites this paper
• Enhanced Oral Bioavailability and Anti-Echinococcosis Efficacy of Albendazole Achieved by Optimizing the "Spring" and "Parachute".

  2019cites this paper
• Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an in vitro/in silico study

  2019cites this paper
• Application of lipocalin-type prostaglandin D synthase ( L-PGDS ) as a novel solubilizer for solid oral dosage forms (リポカリン型プロスタグランジン D 合成酵素の 経口固形製剤開発における新規可溶化剤としての応用)

  2018cites this paper
• Design and Evaluation of Hydrophilic Matrix System for pH-Independent Sustained Release of Weakly Acidic Poorly Soluble Drug

  2018cites this paper
• Amorphous solid dispersions of carvedilol along with pH‐modifiers improved pharmacokinetic properties under hypochlorhydoria

  2018cites this paper
• In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.

  2018cites this paper
• Cryochemically Obtained Nanoforms of Antimicrobial Drug Substance Dioxidine and Their Physico-chemical and Structural Properties

  2018cites this paper
• Development of a fast and efficient liposomal drug loading technology for poorly water soluble drugs : formulation, characterization, and potential applications

  2018cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 257 Biopharmaceutical aspects of intestinal drug absorption Regional permeability and absorption-modifying excipients

  2018cites this paper
• Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion

  2018cites this paper
• Application of an In Vitro Dissolution/Permeation System to Early Screening of Oral Formulations of Poorly Soluble, Weakly Basic Drugs Containing an Acidic pH-Modifier.

  2018cites this paper
• Rational Design of Oral Modified-Release Drug Delivery Systems

  2017cites this paper
• Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies

  2017cites this paper
• Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery

  2017cites this paper
• Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier

  2017cites this paper
• Enhanced dissolution rate and oral bioavailability of ginkgo biloba extract by preparing nanoparticles via emulsion solvent evaporation combined with freeze drying (ESE-FR)

  2016cites this paper
• Bioavailability Improvement Strategies for Poorly Water-Soluble Drugs Based on the Supersaturation Mechanism: An Update.

  2016cites this paper
• In vitro dissolution-permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using μFlux™.

  2015cites this paper
• Thermodynamic Solubility Profile of Carbamazepine-Cinnamic Acid Cocrystal at Different pH.

  2015cites this paper
• Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.

  2015cites this paper
• Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.

  2015cites this paper
• Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model.

  2015cites this paper
• Novel oral formulation approach for poorly water-soluble drug using lipocalin-type prostaglandin D synthase.

  2015cites this paper
• Coamorphous Lurasidone Hydrochloride−Saccharin with Charge- Assisted Hydrogen Bonding Interaction Shows Improved Physical Stability and Enhanced Dissolution with pH-Independent Solubility Behavior

  2015cites this paper
• Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.

  2014cites this paper
• GT 0918 , a developing anti-prostate cancer drug : Preparation , characterization and evaluation in vivo

  2014cites this paper